Cruse Michael
- SEC CIK
- 0001854179
No open-market purchases or sales filed in the past year.
Current role at each company
- OKUR OnKure Therapeutics, Inc.Chief Operating Officeras of Dec 13, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Cruse Michael as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 2, 2022 (view filing) | Sep 1 | 1 day | Cruse MichaelChief Operating Officer | PPurchase | +7.50K | $3.39 | +$25.4K | +121.0%13.7K after | |
| Aug 31, 2022 (view filing) | Aug 29-30 | 2 days | Cruse MichaelChief Operating Officer | PPurchase | +1.06K | $3.17 | +$3.35K | +3.4%31.8K after | 2 lots |
| Aug 31, 2022 (view filing) | Aug 29-31 | 2 days | Cruse MichaelChief Operating Officer | PPurchase | +6.20K | $3.21 | +$19.9K | New position6.20K after | 3 lots |
| Aug 26, 2021 (view filing) | Aug 25 | 1 day | Cruse MichaelSenior VP-Corporate Operations | PPurchase | +2.50K | $7.45 | +$18.6K | New position2.50K after |